相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neurogenesis in the Striatum of the Adult Human Brain
Aurelie Ernst et al.
CELL (2014)
Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington's Disease
Joshua L. Plotkin et al.
NEURON (2014)
Model animals for the study of oxidative stress from complex II
Takamasa Ishii et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2013)
Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntingtons disease
Mali Jiang et al.
HUMAN MOLECULAR GENETICS (2013)
A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers
Jolanta Krzyszton-Russjan et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2013)
Midbrain-Derived Neurotrophins Support Survival of Immature Striatal Projection Neurons
Maryna Baydyuk et al.
JOURNAL OF NEUROSCIENCE (2013)
β-Arrestin-Selective G Protein-Coupled Receptor Agonists Engender Unique Biological Efficacy in Vivo
Diane Gesty-Palmer et al.
MOLECULAR ENDOCRINOLOGY (2013)
VennPlex-A Novel Venn Diagram Program for Comparing and Visualizing Datasets with Differentially Regulated Datapoints
Huan Cai et al.
PLOS ONE (2013)
Textrous!: Extracting Semantic Textual Meaning from Gene Sets
Hongyu Chen et al.
PLOS ONE (2013)
BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior
Dario Besusso et al.
NATURE COMMUNICATIONS (2013)
A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in Glioblastoma
Renee D. Read et al.
PLOS GENETICS (2013)
Changes of Ribosomal Protein S3 Immunoreactivity and Its New Expression in Microglia in the Mice Hippocampus After Lipopolysaccharide Treatment
Hui Young Lee et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Metabolic Dysfunction in Alzheimer's Disease and Related Neurodegenerative Disorders
Huan Cai et al.
CURRENT ALZHEIMER RESEARCH (2012)
Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntingtons Disease - from Clinical Features to the Bench
Tatiana R. Rosenstock et al.
CURRENT DRUG TARGETS (2012)
Euglycemic Agent-mediated Hypothalamic Transcriptomic Manipulation in the N171-82Q Model of Huntington Disease Is Related to Their Physiological Efficacy
Bronwen Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Age-Related Changes in Mouse Taste Bud Morphology, Hormone Expression, and Taste Responsivity
Yu-Kyong Shin et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
7-Nitroindazole down-regulates dopamine/DARPP-32 signaling in neostriatal neurons in a rat model of Parkinson's disease
J. E. Yuste et al.
NEUROPHARMACOLOGY (2012)
Altered Hypothalamic Protein Expression in a Rat Model of Huntington's Disease
Wei-na Cong et al.
PLOS ONE (2012)
Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development
Yun Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
SPARC Stimulates Neuronal Differentiation of Medulloblastoma Cells via the Notch1/STAT3 Pathway
Praveen Bhoopathi et al.
CANCER RESEARCH (2011)
P25a/PPP expression increases plasma membrane presentation of the dopamine transporter and enhances cellular sensitivity to dopamine toxicity
Anja W. Fjorback et al.
FEBS JOURNAL (2011)
The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease
Ignacio Munoz-Sanjuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice
Danielle A. Simmons et al.
NEUROBIOLOGY OF DISEASE (2011)
Amitriptyline-Mediated Cognitive Enhancement in Aged 3xTg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity
Wayne Chadwick et al.
PLOS ONE (2011)
TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons
Maryna Baydyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
Daniel J. Ho et al.
EXPERIMENTAL NEUROLOGY (2010)
Psychotropic Drugs on In Vitro Brain-Derived Neurotrophic Factor Production in Whole Blood Cell Cultures From Healthy Subjects
Bun-Hee Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
Yuxiang Xie et al.
JOURNAL OF NEUROSCIENCE (2010)
Glycolysis Inhibition Decreases the Levels of Glutamate Transporters and Enhances Glutamate Neurotoxicity in the R6/2 Huntington's Disease Mice
Ana Maria Estrada-Sanchez et al.
NEUROCHEMICAL RESEARCH (2010)
Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity
Sung-Wuk Jang et al.
CHEMISTRY & BIOLOGY (2009)
Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease
Bronwen Martin et al.
DIABETES (2009)
Growth Factor Signals in Neural Cells COHERENT PATTERNS OF INTERACTION CONTROL MULTIPLE LEVELS OF MOLECULAR AND PHENOTYPIC RESPONSES
Bronwen Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke
Suresh L. Mehta et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Beyond the brain: widespread pathology in Huntington's disease
Jorien M. M. van der Burg et al.
LANCET NEUROLOGY (2009)
Long-term effects of dietary glycemic index on adiposity, energy metabolism, and physical activity in mice
Kelly B. Scribner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model
Qi Peng et al.
EXPERIMENTAL NEUROLOGY (2008)
Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse
Tomas Deierborg et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice
Kusumika Gharami et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
Naoki Masuda et al.
NEUROBIOLOGY OF DISEASE (2008)
Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease
Wenzhen Duan et al.
NEUROBIOLOGY OF DISEASE (2008)
Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment
R. Hellweg et al.
PHARMACOPSYCHIATRY (2008)
Mutant huntingtin and mitochondrial dysfunction
Ella Bossy-Wetzel et al.
TRENDS IN NEUROSCIENCES (2008)
Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease
Sung-Rae Cho et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excess
Bronwen Martin et al.
ENDOCRINOLOGY (2007)
Nortriptyline delays disease onset in models of chronic neurodegeneration
Hongyan Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease
Danielle A. Simmons et al.
GLIA (2007)
PGC-1α, a new therapeutic target in Huntington's disease?
Jetta K. McGill et al.
CELL (2006)
Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
Libin Cui et al.
CELL (2006)
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain
S Ginés et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Serotonin reuptake inhibitors: The corner stone in treatment of depression for half a century - A medicinal chemistry survey
Ejner K. Moltzen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment
D Zala et al.
NEUROBIOLOGY OF DISEASE (2005)
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
E Brouillet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Mitochondria take center stage in aging and neurodegeneration
MF Beal
ANNALS OF NEUROLOGY (2005)
Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine
HE Grote et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
CR Bramham et al.
PROGRESS IN NEUROBIOLOGY (2005)
p53-defective tumors with a functional apoptosome-mediated pathway: A new therapeutic target
T Mashima et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines
JL Stanley et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor
ZC Baquet et al.
JOURNAL OF NEUROSCIENCE (2004)
Paroxetine retards disease onset and progression in huntingtin mutant mice
WZ Duan et al.
ANNALS OF NEUROLOGY (2004)
Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism
TL Spires et al.
JOURNAL OF NEUROSCIENCE (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma
G Mattiasson et al.
NATURE MEDICINE (2003)
Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, bcl-2 and Cu/Zn-SOD in rat hippocampus
HY Xu et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Protein aggregation in Huntington's disease
G Hoffner et al.
BIOCHIMIE (2002)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease
OA Andreassen et al.
NEUROBIOLOGY OF DISEASE (2001)
Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease
E Pérez-Navarro et al.
JOURNAL OF NEUROCHEMISTRY (2000)
In vivo control of respiration by cytochrome C oxidase in human cells
G Villani et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Brain-derived neurotrophic factor in Huntington disease
I Ferrer et al.
BRAIN RESEARCH (2000)
Down-regulated RPS3a/nbl expression during retinoid-induced differentiation of HL-60 cells:: A close association with diminished susceptibility to actinomycin D-stimulated apoptosis
L Russell et al.
CELL STRUCTURE AND FUNCTION (2000)
分享论文
